Tier IIIProcedure · NIR light142 trials

Photobiomodulation (810 nm) — Near-Infrared Cellular Therapy

Photobiomodulation (PBM) at 810 nm utilizes near-infrared light to stimulate cellular function and enhance mitochondrial energy production. Due to its deep tissue penetration, it is particularly relevant for neuroprotection, cognitive enhancement, and systemic anti-inflammatory effects in longevity protocols.

Not yet available in retail — research compound only

Mechanism of Action

The primary chromophore for 810 nm near-infrared light is cytochrome c oxidase (Complex IV) within the mitochondrial electron transport chain. Absorption of photons by this enzyme facilitates electron transfer, upregulating ATP synthesis and transiently modulating reactive oxygen species (ROS). This mild oxidative stress acts as a hormetic signal, activating downstream transcription factors such as NF-κB and AP-1. Consequently, this cascade promotes the expression of genes involved in cellular repair, neurogenesis, and the suppression of pro-inflammatory cytokines.

Human Trial Evidence

Multiple human trials have investigated 810 nm PBM, particularly for neurological applications. Clinical studies demonstrate improvements in cerebral blood flow, cognitive function in dementia patients, and recovery following traumatic brain injury (TBI). While large-scale, long-term longevity trials are lacking, existing evidence supports its efficacy in enhancing mitochondrial function and mitigating age-related cognitive decline.

Dosing Protocol

Protocols vary based on the target tissue and device (LED or laser). Transcranial applications typically involve 10–20 minute sessions delivering a fluence of 10–30 J/cm², administered 2–4 times per week. Intranasal and whole-body light beds are also utilized, with dosing carefully calibrated to avoid biphasic dose-response inhibition.

Safety & Contraindications

PBM is generally considered highly safe and non-invasive. Mild, transient side effects can include headaches, scalp irritation, or fatigue if overused. It is contraindicated over active malignancies, the thyroid gland (unless specifically targeted), and the eyes without appropriate protective eyewear.

Key Papers

Quick Stats
Evidence TierTier III
Clinical Trials142
Typical DoseDaily
Est. Cost/Day
Purity
Synergistic Compounds
Methylene BlueCoenzyme Q10PQQCreatine
Medical disclaimer: This page is for informational purposes only. Consult a qualified healthcare provider before starting any supplement regimen. Vitaei does not provide medical advice.